Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Immunity
|
August 27, 2011
A new vampire saga: the molecular mechanism of T cell trogocytosis
Elaine Pashupati Dopfer, Susana Minguet, Wolfgang W A Schamel
International Immunology
|
February 11, 2010
Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR)
Susana Minguet, Elaine-Pashupati Dopfer, Wolfgang W A Schamel
Journal of Gastrointestinal Cancer
|
January 14, 2026
Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?
Maryam Barsch, Elaine-Pashupati Dopfer, Anne Maria Schultheis, et al.
Current Pharmaceutical Design
|
October 29, 2009
Models of antigen receptor activation in the design of vaccines
Eszter Molnár, Elaine-Pashupati Dopfer, Sumit Deswal, et al.
Immunity
|
May 19, 2016
A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation
Mahima Swamy, Katharina Beck-Garcia, Esmeralda Beck-Garcia, et al.
Pathologie (Heidelberg, Germany)
|
June 27, 2025
[Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board]
Elaine-Pashupati Dopfer, Matthias Fahrner, Johanna Thiery, et al.
Neuroendocrinology
|
May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms
Maryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Blood
|
July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
Jenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Immunity
|
August 27, 2011
A new vampire saga: the molecular mechanism of T cell trogocytosis
Elaine Pashupati Dopfer, Susana Minguet, Wolfgang W A Schamel
International Immunology
|
February 11, 2010
Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR)
Susana Minguet, Elaine-Pashupati Dopfer, Wolfgang W A Schamel
Journal of Gastrointestinal Cancer
|
January 14, 2026
Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?
Maryam Barsch, Elaine-Pashupati Dopfer, Anne Maria Schultheis, et al.
Current Pharmaceutical Design
|
October 29, 2009
Models of antigen receptor activation in the design of vaccines
Eszter Molnár, Elaine-Pashupati Dopfer, Sumit Deswal, et al.
Immunity
|
May 19, 2016
A Cholesterol-Based Allostery Model of T Cell Receptor Phosphorylation
Mahima Swamy, Katharina Beck-Garcia, Esmeralda Beck-Garcia, et al.
Pathologie (Heidelberg, Germany)
|
June 27, 2025
[Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board]
Elaine-Pashupati Dopfer, Matthias Fahrner, Johanna Thiery, et al.
Neuroendocrinology
|
May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasms
Maryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Blood
|
July 19, 2022
Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
Jenny N H G Ho, Dominik Schmidt, Theresa Lowinus, et al.
Page
of 1